Endocrysis
United States
| Agent | Usage | RND | Rating2.0 | ACS | K:D | ADR | KAST | KPR | APR | FKPR | FDPR | K | D | A | FK | FD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
17 (74%) | 373 | 0.84 | 151.2 | 0.78 | 104.9 | 68.6% | 0.52 | 0.23 | 0.05 | 0.08 | 194 | 250 | 85 | 17 | 28 |
|
1 (4%) | 17 | 0.79 | 180.0 | 0.73 | 107.0 | 65.0% | 0.65 | 0.29 | 0.12 | 0.06 | 11 | 15 | 5 | 2 | 1 |
|
4 (17%) | 75 | 0.68 | 142.0 | 0.63 | 93.8 | 68.1% | 0.47 | 0.37 | 0.03 | 0.08 | 35 | 56 | 28 | 2 | 6 |
|
1 (4%) | 21 | 0.36 | 58.0 | 0.25 | 42.0 | 62.0% | 0.19 | 0.05 | 0.0 | 0.1 | 4 | 16 | 1 | 0 | 2 |